Sophie Langenskiöld
Biographic Data
| ID | 7688943 |
|---|---|
| NAME | Sophie Langenskiöld |
| GIVEN NAMES | Sophie |
| FAMILY NAME | Langenskiöld |
| SIGNATURE | LANGENSKIÖLD S |
| AFFILIATIONS | Uppsala University |
| ORCID | 0000-0003-3888-2910 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2019 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 0 |
Avoiding Routine Oxygen Therapy in Patients With Myocardial Infarction Saves Significant Expenditure for the Health Care System—Insights From the Randomized Deto2X-AMI Trial
Background: Myocardial infarction (MI) occurs frequently and requires considerable health care resources. It is important to ensure that the treatments which are provided are both clinically effective and economically justifiable. Based on recent new evidence, routine oxygen therapy is no longer recommended in MI patients without hypoxemia. By using data from a nationwide randomized clinical trial, we estimated oxygen therapy related cost savings…
Influence of elicitation procedure and phrasing on health state valuations in experience-based time trade-off tasks among diabetes patients in China
The choice of elicitation procedure as well as the description of experience-based TTO tasks may influence the valuation of health states. Further research is warranted, also in other cultural contexts, to further explore these findings
No prominent works on this page.
Influence of elicitation procedure and phrasing on health state valuations in experience-based time trade-off tasks among diabetes patients in China
The choice of elicitation procedure as well as the description of experience-based TTO tasks may influence the valuation of health states. Further research is warranted, also in other cultural contexts, to further explore these findings
Avoiding Routine Oxygen Therapy in Patients With Myocardial Infarction Saves Significant Expenditure for the Health Care System—Insights From the Randomized Deto2X-AMI Trial
Background: Myocardial infarction (MI) occurs frequently and requires considerable health care resources. It is important to ensure that the treatments which are provided are both clinically effective and economically justifiable. Based on recent new evidence, routine oxygen therapy is no longer recommended in MI patients without hypoxemia. By using data from a nationwide randomized clinical trial, we estimated oxygen therapy related cost savings…
Medicine (2 works) · Acute Myocardial Infarction Research (1 work) · Blood Pressure and Hypertension Studies (1 work) · Cardiac Arrest and Resuscitation (1 work) · Cardiology (1 work) · Clinical trial (1 work) · Decision-Making and Behavioral Economics (1 work) · Economics (1 work) · Emergency Medicine (1 work) · Environmental health (1 work)